HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between a DJ-1 polymorphism and the risk of Parkinson's disease: a PRISMA-compliant systematic review and meta-analysis.

AbstractOBJECTIVE:
In recent years, a number of case-control studies have focused on the association between the DJ-1 g.168_185del polymorphism and the risk of Parkinson's disease (PD). However, the results have been conflicting. To estimate the relationship between the DJ-1 g.168_185del polymorphism and PD susceptibility, a comprehensive meta-analysis was performed.
METHODS:
Eligible studies concerning the DJ-1 g.168_185del polymorphism and PD susceptibility were searched for in the PubMed, Web of Science, Embase, Wanfang, CNKI, and VIP databases. Odds ratios and 95% confidence intervals were calculated to estimate the strength of the associations. In total, 11 studies were included in this meta-analysis, including 13 case-control studies with 2890 cases and 3043 controls.
RESULTS:
This meta-analysis revealed that DJ-1 g.168_185del variants are associated with PD susceptibility in the non-Asian population, but not in the Asian population.
CONCLUSIONS:
Our meta-analysis suggests that DJ-1 gene variants are not associated with the risk of PD in the overall population.
AuthorsJie Liu, Chunrong Li, Xiaoyang Zhou, Jian Sun, Meng Zhu, Hongliang Zhang, Lei Cheng, Guobin Li, Tao He, Wenshuai Deng
JournalThe Journal of international medical research (J Int Med Res) Vol. 48 Issue 8 Pg. 300060520947943 (Aug 2020) ISSN: 1473-2300 [Electronic] England
PMID32814486 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
Chemical References
  • PARK7 protein, human
  • Protein Deglycase DJ-1
Topics
  • Asian People
  • Case-Control Studies
  • Genetic Predisposition to Disease
  • Humans
  • Odds Ratio
  • Parkinson Disease (genetics)
  • Polymorphism, Genetic
  • Polymorphism, Single Nucleotide
  • Protein Deglycase DJ-1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: